Skip to content

Registration for 2024 Annual Ataxia Conference is NOW OPEN! Early-bird discount available for a limited time.  LEARN MORE!

Article Summary

Regional differences in BDNF levels provide new insights into SCA1 pathology

Written by Rana Abdelhalim Edited by Dr. Spyros Petrakis Early BDNF delivery improved cognitive and motor deficits while ameliorating cerebellar pathology in a SCA1 mouse model. Cognitive impairment, slurred speech, difficulty with balance and walking— these are all symptoms of spinocerebellar ataxia type 1 (SCA1). SCA1 is an inherited neurodegenerative Read More…

SCAview: Big Data for Big Questions

Written by Dr. Celeste SuartEdited by Priscila Pereira Sena An international group of researchers developed a new tool for looking at large datasets of spinocerebellar ataxia clinical information. Spinocerebellar ataxias (SCAs) are the most common form of dominantly inherited ataxia worldwide. Since SCAs are rare diseases, it can be hard Read More…

Getting ready for trials in SCA1 and SCA3 with imaging

Written by Dr. Gülin ÖzEdited by Dr. Celeste Suart Advanced Magnetic Resonance Imaging (MRI) detects brain changes before ataxia symptoms. The list of pharmaceutical companies that turned their attention to ataxias has been steadily increasing over the last decade. This is in large part thanks to exciting developments in gene Read More…

Damage to DNA is linked to neuron death in SCA7

Written By Dr. Hannah K ShorrockEdited by Dr. Celeste Suart Accumulating DNA damage without being able to repair it may lead to a cascade of negative effects in SCA7, resulting in neuronal demise and death. Why do neurons in the cerebellum degenerate in spinocerebellar ataxia type 7? If scientists can Read More…

Um esforço contínuo em direção ao tratamento da SCA3

Escrito por Dr. Jorge Diogo Da Silva Editado por Dr. David Bushart Traduzido para o português por Priscila Pereira Sena Como um grupo de pesquisa avaliou se a Rivastigmina, uma droga usada no tratamento da doença de Parkinson, pode exercer um papel no tratamento da SCA3 Ataxia Espinocerebelar do tipo Read More…

Spinocerebellar Ataxia Type 8: Lifetime risk and repeat interruptions

Written by Dr. Hannah K ShorrockEdited by Dr. Larissa Nitschke Differences in the lifetime risk of developing SCA8 are associated with the presence of interruptions in the ATXN8 repeat expansion. In most spinocerebellar ataxias caused by repeat expansions, everyone who carries a repeat expansion above a certain threshold will develop Read More…

Translate »

Join the Ataxia community today!

Become a free member for exclusive content from NAF.